Key points are not available for this paper at this time.
Amplicon sequencing protocol for SARS-CoV-2 v4 (LSK114) We thank the ARTIC network, Oxford Nanopore Technologies, New England Biolabs, BCCDC, COG-UK, CanCOGen and protocols.io commenters for their assistance developing this protocol. Changes in this version: -Up to 95 samples per run with EXP-NBD196 native barcode kit -Substitution of SuperScript IV for LunaScript RT SuperMix and reaction volume reduced to 10 uL. -Substitution of Ultra II Ligation Module for Blunt/TA Ligase Master Mix and reaction volume reduced to 10 µL. -Native barcode ligation reaction volume reduced to 10 uL. -SFB wash volume reduced.
Quick et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: